Non-Cystic Fibrosis Bronchiectasis Therapy Developer Aradigm Appoints Dr. Robert A. Reed as Vice President, Regulatory
News
Hayward, California-based Aradigm Corporation, an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for prevention and treatment of severe respiratory diseases, has announced ... Read more